Literature DB >> 8964823

Long-term tamoxifen therapy: can an antagonist become an agonist?

R J Santen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8964823     DOI： 10.1210/jcem.81.6.8964823

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  3 in total

1.  Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.

Authors:  Wei Lv; Jinzhong Liu; Todd C Skaar; David A Flockhart; Mark Cushman
Journal:  J Med Chem       Date:  2015-03-09       Impact factor: 7.446

2.  Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.

Authors:  Peter Kabos; Jessica Finlay-Schultz; Chunling Li; Enos Kline; Christina Finlayson; Joshua Wisell; Christopher A Manuel; Susan M Edgerton; J Chuck Harrell; Anthony Elias; Carol A Sartorius
Journal:  Breast Cancer Res Treat       Date:  2012-07-24       Impact factor: 4.872

3.  Effects of tamoxifen on GH and IGF-I levels in acromegaly.

Authors:  R Cozzi; R Attanasio; G Oppizzi; P Orlandi; A Giustina; S Lodrini; N Da Re; D Dallabonzana
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.